KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Finished Goods (2016 - 2025)

Historic Finished Goods for Pacific Biosciences Of California (PACB) over the last 15 years, with Q3 2025 value amounting to $16.4 million.

  • Pacific Biosciences Of California's Finished Goods fell 186.89% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 186.89%. This contributed to the annual value of $14.1 million for FY2024, which is 1057.41% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Finished Goods of $16.4 million as of Q3 2025, which was down 186.89% from $14.8 million recorded in Q2 2025.
  • Pacific Biosciences Of California's Finished Goods' 5-year high stood at $19.8 million during Q2 2023, with a 5-year trough of $3.7 million in Q2 2021.
  • Moreover, its 5-year median value for Finished Goods was $14.1 million (2024), whereas its average is $12.4 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Finished Goods crashed by 3522.17% in 2021, and later soared by 15165.35% in 2023.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Finished Goods stood at $8.0 million in 2021, then surged by 52.35% to $12.2 million in 2022, then increased by 29.28% to $15.7 million in 2023, then decreased by 10.57% to $14.1 million in 2024, then increased by 16.72% to $16.4 million in 2025.
  • Its Finished Goods was $16.4 million in Q3 2025, compared to $14.8 million in Q2 2025 and $13.4 million in Q1 2025.